OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Current Advances in Zika Vaccine Development
Yuchen Wang, Ling Lin, Zilei Zhang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1816-1816
Open Access | Times Cited: 57
Yuchen Wang, Ling Lin, Zilei Zhang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1816-1816
Open Access | Times Cited: 57
HBV Vaccines: Advances and Development
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 17
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 17
Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome
Saja Fadila, Bertrand Beucher, Iria G. Dopeso‐Reyes, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 16
Saja Fadila, Bertrand Beucher, Iria G. Dopeso‐Reyes, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 16
An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?
Gustavo Saint-Pierre, Daniel Conei, Luis Lizama, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 330-330
Open Access | Times Cited: 15
Gustavo Saint-Pierre, Daniel Conei, Luis Lizama, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 330-330
Open Access | Times Cited: 15
Towards a unified approach in managing resistance to vaccines, drugs, and pesticides
Andrei Alyokhin, Benjamin M. Rosenthal, Donald C. Weber, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2025)
Closed Access
Andrei Alyokhin, Benjamin M. Rosenthal, Donald C. Weber, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2025)
Closed Access
Heterologous Prime-Boost immunization with Adenoviral vector and recombinant subunit vaccines strategies against dengue virus type2
M Mahmoudian Shoushtari, Mostafa Salehi-Vaziri, Maryam Kadkhodazadeh, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114032-114032
Closed Access
M Mahmoudian Shoushtari, Mostafa Salehi-Vaziri, Maryam Kadkhodazadeh, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114032-114032
Closed Access
In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology
Julie Schock Vaiani, Mans Broekgaarden, Jean‐Luc Coll, et al.
Nanoscale (2025)
Closed Access
Julie Schock Vaiani, Mans Broekgaarden, Jean‐Luc Coll, et al.
Nanoscale (2025)
Closed Access
In vivo targeted gene delivery using Adenovirus-antibody molecular glue conjugates
Paul Boucher, Elena A. Kashentseva, Igor P. Dmitriev, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Paul Boucher, Elena A. Kashentseva, Igor P. Dmitriev, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Pseudotyped Replication-Deficient VSV with Spike from PEDV Induces Neutralizing Antibody Against PEDV
Jingxuan Yi, Huaye Luo, Kang Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 223-223
Open Access
Jingxuan Yi, Huaye Luo, Kang Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 223-223
Open Access
From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 4
Closed Access
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 4
Closed Access
Clinical Application of Adenovirus (AdV): A Comprehensive Review
Md. Salauddin, Sukumar Saha, Md. Golzar Hossain, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 4
Md. Salauddin, Sukumar Saha, Md. Golzar Hossain, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 4
Reverse Engineering of a Pathogenic Antibody Reveals the Molecular Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia
Daniil G. Ivanov, Nikola Ivetic, Yi Du, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 46, pp. 25203-25213
Open Access | Times Cited: 10
Daniil G. Ivanov, Nikola Ivetic, Yi Du, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 46, pp. 25203-25213
Open Access | Times Cited: 10
Versatile nanorobot hand biosensor for specific capture and ultrasensitive quantification of viral nanoparticles
Rui Li, Ya Zhao, Hongli Fan, et al.
Materials Today Bio (2022) Vol. 16, pp. 100444-100444
Open Access | Times Cited: 15
Rui Li, Ya Zhao, Hongli Fan, et al.
Materials Today Bio (2022) Vol. 16, pp. 100444-100444
Open Access | Times Cited: 15
Immunotherapy: A new target for cancer cure (Review)
Fuqian Zhao, Dao-fu Shen, Mingquan Shang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 8
Fuqian Zhao, Dao-fu Shen, Mingquan Shang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 8
Structural Characterization of a Pathogenic Antibody Underlying Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
Son Nguyen, Si-Hung Le, Daniil G. Ivanov, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 16, pp. 6209-6217
Open Access | Times Cited: 2
Son Nguyen, Si-Hung Le, Daniil G. Ivanov, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 16, pp. 6209-6217
Open Access | Times Cited: 2
Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
Prashant Kumar, Michael Wang, Ozan S. Kumru, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 103-121
Open Access | Times Cited: 5
Prashant Kumar, Michael Wang, Ozan S. Kumru, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 103-121
Open Access | Times Cited: 5
Epidemiological aspects of headache after different types of COVID ‐19 vaccines: An online survey
Rehab Magdy, Diana Khedr, Osama Yacoub, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 8, pp. 1046-1052
Open Access | Times Cited: 9
Rehab Magdy, Diana Khedr, Osama Yacoub, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 8, pp. 1046-1052
Open Access | Times Cited: 9
A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies
Zhaobin Xu, Jian Song, Hongmei Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Zhaobin Xu, Jian Song, Hongmei Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Nanovaccines to combat virus‐related diseases
Fuhua Wu, Ming Qin, Hairui Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 2
Closed Access | Times Cited: 8
Fuhua Wu, Ming Qin, Hairui Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 2
Closed Access | Times Cited: 8
Adenoviral vectors infect B lymphocytes in vivo
Paul Boucher, Samir Andrade Mendonça, Aluet Borrego Alvarez, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2600-2611
Open Access | Times Cited: 4
Paul Boucher, Samir Andrade Mendonça, Aluet Borrego Alvarez, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2600-2611
Open Access | Times Cited: 4
Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
Tasneem Farhad, Keila Neves, Patrick Arbuthnot, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1941-1941
Open Access | Times Cited: 6
Tasneem Farhad, Keila Neves, Patrick Arbuthnot, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1941-1941
Open Access | Times Cited: 6
Structural characterization of a pathogenic antibody underlying vaccine-induced immune thrombotic thrombocytopenia (VITT)
Son Nguyen, Si-Hung Le, Daniil G. Ivanov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Son Nguyen, Si-Hung Le, Daniil G. Ivanov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
CRISPR-Cas9 expressed in stably transduced cell lines promotes recombination and selects for herpes simplex virus recombinants
Hyung Suk Oh, Fernando Dı́az, Changhong Zhou, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100023-100023
Open Access | Times Cited: 4
Hyung Suk Oh, Fernando Dı́az, Changhong Zhou, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100023-100023
Open Access | Times Cited: 4
Zika virus infection- a new challenge for global health
Natalia Garuchava, Marina Kuparadze, Gigi Gorgadze, et al.
(2024)
Open Access
Natalia Garuchava, Marina Kuparadze, Gigi Gorgadze, et al.
(2024)
Open Access
